Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer's disease.
about
Who fans the flames of Alzheimer's disease brains? Misfolded tau on the crossroad of neurodegenerative and inflammatory pathways3D Visualization of the Temporal and Spatial Spread of Tau Pathology Reveals Extensive Sites of Tau Accumulation Associated with Neuronal Loss and Recognition Memory Deficit in Aged Tau Transgenic MiceModeling Alzheimer's disease in transgenic ratsCharacterization of neuropathology in the HIV-1 transgenic rat at different ages.Long-term trihexyphenidyl exposure alters neuroimmune response and inflammation in aging rat: relevance to age and Alzheimer's diseaseAssessing the contribution of inflammation in models of Alzheimer's disease.Tauopathy in transgenic (SHR72) rats impairs function of central noradrenergic system and promotes neuroinflammation.Genomic background-related activation of microglia and reduced β-amyloidosis in a mouse model of Alzheimer's disease.Metabolic status of CSF distinguishes rats with tauopathy from controls.Microglia display modest phagocytic capacity for extracellular tau oligomers.Tau hyperphosphorylation in synaptosomes and neuroinflammation are associated with canine cognitive impairment.Stress-Induced Alterations of Immune Profile in Animals Suffering by Tau Protein-Driven Neurodegeneration.Immunomodulation of memory-impairing protein tau in Alzheimer's disease.Neuronal Expression of Truncated Tau Efficiently Promotes Neurodegeneration in Animal Models: Pitfalls of Toxic Oligomer Analysis.Ten Years of Tau-Targeted Immunotherapy: The Path Walked and the Roads Ahead
P2860
Q26830542-F1EF25B6-3353-44EA-B8AC-E84791A2204AQ27334236-C4020641-0E52-45D3-859A-4C9628AFE7FAQ34508624-27F0D6C3-96BF-4E30-A64D-DB0B0308FD23Q36655192-97FD673C-B482-47B8-986F-C847B661D8DFQ37089887-83650234-BDE7-479B-A4BC-2F2E45BB4570Q37905123-D3DEF840-8515-422C-AFDD-887712094345Q40080984-99F9D10D-2E65-451B-98EE-BB7083F83042Q41552181-6203F993-F285-43F5-A809-D60E15B9740AQ41690749-0077858E-D69B-494A-839A-CB96F96DB004Q42911754-7372FCA6-83A7-45E2-AED2-0023FF84C59FQ47949668-A69D1C07-D856-4266-9E5E-B8CE3C609CA3Q48281041-3933DD66-EDDD-4CB0-8F44-58851A57CB8DQ50961266-8E326DB6-C756-496E-92FF-DC1DE289B0CCQ50990954-FA2A5E3C-15B0-42E8-B82D-509163A5B129Q59137449-BB7A7F22-18DE-4397-A3EB-D088B0464087
P2860
Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer's disease.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Genetic background modifies ne ...... proach to Alzheimer's disease.
@en
Genetic background modifies ne ...... proach to Alzheimer's disease.
@nl
type
label
Genetic background modifies ne ...... proach to Alzheimer's disease.
@en
Genetic background modifies ne ...... proach to Alzheimer's disease.
@nl
prefLabel
Genetic background modifies ne ...... proach to Alzheimer's disease.
@en
Genetic background modifies ne ...... proach to Alzheimer's disease.
@nl
P2093
P2860
P356
P1476
Genetic background modifies ne ...... proach to Alzheimer's disease.
@en
P2093
Branislav Kovacech
Michal Novak
Norbert Zilka
Ondrej Bugos
Petr Novak
Zuzana Stozicka
P2860
P2888
P356
10.1186/1742-2094-7-64
P577
2010-10-12T00:00:00Z
P5875
P6179
1048774309